31
Participants
Start Date
March 31, 2012
Primary Completion Date
February 28, 2014
Study Completion Date
February 28, 2014
fluorouracil/irinotecan/levo-folinic acid/bevacizumab
standard first line chemotherapy with: bevacizumab 5 mg/kg intravenous (i.v.) infusion on day 1; irinotecan 180 mg/m2 i.v. infusion on day 1, levo-folinic acid 200 mg/m2 i.v. infusion on day 1, 5-fluorouracil 400 mg/m2 i.v. bolus on day 1 and 2,400 mg/m2 i.v. infusion over 46 hours; infusions repeated every 2 weeks
'Tor Vergata' University Hospital, Rome
University of Rome Tor Vergata
OTHER